1 |
Del Follo-Martinez, A., Banerjee, N., Li, X., Safe, S. and Mertens-Talcott, S. (2013) Resveratrol and quercetin in combination have anticancer activity in colon cancer cells and repress oncogenic microRNA-27a. Nutr. Cancer 65, 494-504.
DOI
|
2 |
ElAttar, T. M. and Virji, A. S. (1999) Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation. Anticancer Drugs 10, 187-193.
DOI
|
3 |
Friedewald, W. T., Levy, R. I. and Fredrickson, D. S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499-502.
|
4 |
Go, H. K., Rahman, M. M., Kim, G. B., Na, C. S., Song, C. H., Kim, J. S., Kim, S. J. and Kang, H. S. (2015) Antidiabetic effects of yam (dioscorea batatas) and its active constituent, allantoin, in a rat model of streptozotocin-induced diabetes. Nutrients 7, 8532-8544.
DOI
|
5 |
Gumaa, K. A. and McLean, P. (1972) The kinetic quantitation of ATP: D-glucose 6-phosphotransferases. FEBS Lett. 27, 293-297.
DOI
|
6 |
Gupta, D., Raju, J., Prakash, J. and Baquer, N. Z. (1999) Change in the lipid profile, lipogenic and related enzymes in the livers of experimental diabetic rats: effect of insulin and vanadate. Diabetes Res. Clin. Pract. 46, 1-7.
DOI
|
7 |
Igura, K., Ohta, T., Kuroda, Y. and Kaji, K. (2001) Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett. 171, 11-16.
|
8 |
Machha, A., Achike, F. I., Mustafa, A. M. and Mustafa, M. R. (2007) Quercetin, a flavonoid antioxidant, modulates endothelium-derived nitric oxide bioavailability in diabetic rat aortas. Nitric Oxide 16, 442-447.
|
9 |
Kulkarni, C. R., Joglekar, M. M., Patil, S. B. and Arvindekar, A. U. (2012) Antihyperglycemic and antihyperlipidemic effect of Santalum album in streptozotocin induced diabetic rats. Pharm. Biol. 50, 360-365.
DOI
|
10 |
Kurukulasuriya, R., Link, J. T., Madar, D. J., Pei, Z., Rohde, J. J., Richards, S. J., Souers, A. J. and Szczepankiewicz, B. G. (2003) Prospects for pharmacologic inhibition of hepatic glucose production. Curr. Med. Chem. 10, 99-121.
DOI
|
11 |
McLellan, A. C., Thornalley, P. J., Benn, J. and Sonksen, P. H. (1994) Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin. Sci. (Lond.) 87, 21-29.
|
12 |
Oshaghi, E. A., Goodarzi, M. T., Higgins, V. and Adeli, K. (2017) Role of resveratrol in the management of insulin resistance and related conditions: mechanism of action. Crit. Rev. Clin. Lab. Sci. 54, 267-293.
DOI
|
13 |
Palsamy, P. and Subramanian, S. (2009) Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats. Chem. Biol. Interact. 179, 356-362.
DOI
|
14 |
Palsamy, P. and Subramanian, S. (2011) Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochim. Biophys. Acta 1812, 719-731.
DOI
|
15 |
Rolo, A. P. and Palmeira, C. M. (2006) Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharmacol. 212, 167-178.
DOI
|
16 |
Zhou, B., Zou, H. and Xu, G. (2016) Clinical utility of serum cystatin c in predicting diabetic nephropathy among patients with diabetes mellitus: a meta-analysis. Kidney Blood Press. Res. 41, 919-928.
DOI
|
17 |
Zhou, M., Wang, S., Zhao, A., Wang, K., Fan, Z., Yang, H., Liao, W., Bao, S., Zhao, L., Zhang, Y., Yang, Y., Qiu, Y., Xie, G., Li, H. and Jia, W. (2012) Transcriptomic and metabonomic profiling reveal synergistic effects of quercetin and resveratrol supplementation in high fat diet fed mice. J. Proteome Res. 11, 4961-4971.
DOI
|
18 |
Piwkowska, A., Rogacka, D., Audzeyenka, I., Jankowski, M. and Angielski, S. (2011) High glucose concentration affects the oxidant-antioxidant balance in cultured mouse podocytes. J. Cell. Biochem. 112, 1661-1672.
|
19 |
Rahman, M. M., Lee, S. J., Mun, A. R., Adam, G. O., Park, R. M., Kim, G. B., Kang, H. S., Kim, J. S., Kim, S. J. and Kim, S. Z. (2014) Relationships between blood Mg2+ and energy metabolites/enzymes after acute exhaustive swimming exercise in rats. Biol. Trace Elem. Res. 161, 85-90.
DOI
|
20 |
Ramesh, B. and Pugalendi, K. V. (2006) Antihyperglycemic effect of umbelliferone in streptozotocin-diabetic rats. J. Med. Food 9, 562-566.
DOI
|
21 |
Roslan, J., Giribabu, N., Karim, K. and Salleh, N. (2017) Quercetin ameliorates oxidative stress, inflammation and apoptosis in the heart of streptozotocin-nicotinamide-induced adult male diabetic rats. Biomed. Pharmacother. 86, 570-582.
DOI
|
22 |
Saisho, Y., Kou, K., Tanaka, K., Abe, T., Kurosawa, H., Shimada, A., Meguro, S., Kawai, T. and Itoh, H. (2011) Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes. Endocr. J. 58, 315-322.
DOI
|
23 |
West, I. C. (2000) Radicals and oxidative stress in diabetes. Diabet. Med. 17, 171-180.
DOI
|
24 |
Vessal, M., Hemmati, M. and Vasei, M. (2003) Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 135C, 357-364.
|
25 |
Vidal-Puig, A. and O'Rahilly, S. (2001) Metabolism. Controlling the glucose factory. Nature 413, 125-126.
DOI
|
26 |
Wang, G. G., Lu, X. H., Li, W., Zhao, X. and Zhang, C. (2011) Protective effects of luteolin on diabetic nephropathy in STZ-induced diabetic rats. Evid. Based. Complement. Alternat. Med. 2011, 323171.
|
27 |
Wild, S., Roglic, G., Green, A., Sicree, R. and King, H. (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047-1053.
DOI
|
28 |
Tahrani, A. A., Piya, M. K., Kennedy, A. and Barnett, A. H. (2010) Glycaemic control in type 2 diabetes: targets and new therapies. Pharmacol. Ther. 125, 328-361.
DOI
|
29 |
Su, H. C., Hung, L. M. and Chen, J. K. (2006) Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am. J. Physiol. Endocrinol. Metab. 290, E1339-E1346.
DOI
|
30 |
Szkudelski, T. and Szkudelska, K. (2011) Anti-diabetic effects of resveratrol. Ann. N. Y. Acad. Sci. 1215, 34-39.
DOI
|
31 |
Zak, B., Epstein, E. and Baginski, E. S. (1977) Determination of liver microsomal glucose-6-phosphatase. Ann. Clin. Lab. Sci. 7, 169-177.
|
32 |
Wilson, J. F. (2010) In clinic. Diabetic ketoacidosis. Ann. Intern. Med. 152, ITC1-1, ITC1-2, ITC1-3,ITC1-4, ITC1-5, ITC1-6, ITC1-7, ITC1-8, ITC1-9, ITC1-10, ITC1-11, ITC1-12, ITC1-13, ITC1-14, ITC1-15, table of contents; quiz ITC1-16.
|
33 |
Yim, S., Malhotra, A. and Veves, A. (2007) Antioxidants and CVD in diabetes: where do we stand now? Curr. Diab. Rep. 7, 8-13.
DOI
|
34 |
Yonamine, C. Y., Pinheiro-Machado, E., Michalani, M. L., Freitas, H. S., Okamoto, M. M., Correa-Giannella, M. L. and Machado, U. F. (2016) Resveratrol improves glycemic control in insulin-treated diabetic rats: participation of the hepatic territory. Nutr. Metab. (Lond.) 13, 44.
|
35 |
Zamin, L. L., Filippi-Chiela, E. C., Dillenburg-Pilla, P., Horn, F., Salbego, C. and Lenz, G. (2009) Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells. Cancer Sci. 100, 1655-1662.
DOI
|
36 |
Cersosimo, E., Solis-Herrera, C., Trautmann, M. E., Malloy, J. and Triplitt, C. L. (2014) Assessment of pancreatic beta-cell function: review of methods and clinical applications. Curr. Diabetes Rev. 10, 2-42.
DOI
|
37 |
American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33, S62-S69.
DOI
|
38 |
Arias, N., Macarulla, M. T., Aguirre, L., Milton, I. and Portillo, M. P. (2016) The combination of resveratrol and quercetin enhances the individual effects of these molecules on triacylglycerol metabolism in white adipose tissue. Eur. J. Nutr. 55, 341-348.
|
39 |
Baquer, N. Z., Cascales, M., McLean, P. and Greenbaum, A. L. (1976) Effects of thyroid hormone deficiency on the distribution of hepatic metabolites and control of pathways of carbohydrate metabolism in liver and adipose tissue of the rat. Eur. J. Biochem. 68, 403-413.
DOI
|
40 |
Ceriello, A. (2005) Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 54, 1-7.
DOI
|
41 |
Chen, S., Jiang H., Wu, X. and Fang, J. (2016) Therapeutic effects of quercetin on inflammation, obesity, and type 2 diabetes. Mediators Inflamm. 2016, 9340637.
|